Disclaimer: This news article is copyrighted by Associated Press and published by PR-inside.com. If you have any questions regarding information in this article please contact ap-online.com. PR-inside can not assist or help you giving information

...and central nervous system disorders. We have ongoing joint initiatives with major pharmaceutical companies including Merck, AstraZeneca, Abbott and Takeda, other healthcare organizations including Humana and Philips and the U.S. Food and Drug Administration....

...two, much smaller stem cell collaborations. One is the UK Stem Cells for Safer Medicines consortium, also involving AstraZeneca and Roche, which is developing techniques to use stem cells for safety testing of new drugs. The other is an alliance on cancer...

...by the United States Food and Drug Administration for the acute treatment of migraine attacks in adults, and with AstraZeneca for proprietary fixed dose combinations of naproxen with the proton pump inhibitor esomeprazole magnesium in a single tablet for conditions...

...are for saxagliptin, following clinical trials of the drug. Onglyza is the companies' proposed trade name. The announcement came a day before Bristol-Myers announces its first quarter results. AstraZeneca gives a third quarter update on July 31. ...

...because myopathy is a class effect," they said. Cholesterol-lowering drugs such as Zocor, Pfizer Inc.'s Lipitor and AstraZeneca Plc's Crestor generated $33.7 billion in worldwide sales in 2007, according to IMS Health, a Norwalk, Connecticut-based research...

...Head Expert OBIG- Austrian Health Institute- Health Economist Leading Pharmaceutical Companies Amgen- Medical Director CEE AstraZeneca- Medical Director, Leader for CEE Pricing & Reimbursement Group Communication Respected Doctors University Hospital Zagreb-...

...interferon beta-1b (Betaseron) for the treatment of multiple sclerosis. His former positions included Oncology Group Leader at AstraZeneca, UK, Director Clinical Developments & Regulatory Affairs, SmithKline Beecham, Belgium, and Therapeutic Director Immunology...

...to Industrial Info Resources, a research firm. In fact, another 26 are still scheduled to be shuttered, including an AstraZeneca facility in Ontario; a pair of Biovail plants in Puerto Rico; a Bristol-Myers Squibb facility in Puerto Rico, and a Barr Pharmaceuticals...

...for metastatic colorectal cancer; and therapies for hepatitis B and C. Our preclinical asthma and COPD program is partnered with AstraZeneca. The NIH partially funds our preclinical work on a universal vaccine for influenza. Symphony Dynamo Inc. (SDI) funds...